JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M502469200 on June 1, 2005

J. Biol. Chem., Vol. 280, Issue 31, 28370-28381, August 5, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/31/28370    most recent
M502469200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ljusberg, J.
Right arrow Articles by Andersson, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ljusberg, J.
Right arrow Articles by Andersson, G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Proteolytic Excision of a Repressive Loop Domain in Tartrate-resistant Acid Phosphatase by Cathepsin K in Osteoclasts*

Jenny Ljusberg{ddagger}, Yunling Wang{ddagger}, Pernilla Lång{ddagger}, Maria Norgård{ddagger}, Robert Dodds§, Kjell Hultenby{ddagger}, Barbro Ek-Rylander{ddagger}, and Göran Andersson{ddagger}||

From the {ddagger}Department of Laboratory Medicine, Divisions of Pathology and Clinical Research Centre, Karolinska Institutet, Karolinska University Hospital, S-141 86 Huddinge, Sweden and §Growth Factors Drug Discovery, Johnson and Johnson Pharmaceutical Research and Development, Raritan, New Jersey 08869

Tartrate-resistant acid phosphatase (TRAP) is a metallophosphoesterase participating in osteoclast-mediated bone turnover. Activation of TRAP is associated with the redox state of the di-iron metal center as well as with limited proteolytic cleavage in an exposed loop domain. The cysteine proteinases cathepsin B, L, K, and S as well as the matrix metalloproteinase-2, -9, -13, and -14 are expressed by osteoclasts and/or other bone cells and have been implicated in the turnover of bone and cartilage. To identify proteases that could act as activators of TRAP in bone, we report here that cathepsins K and L, in contrast to the matrix metalloproteinases, efficiently cleaved and activated recombinant TRAP in vitro. Activation of TRAP by cathepsin K/L was because of increases in catalytic activity, substrate affinity, and sensitivity to reductants. Processing by cathepsin K occurred sequentially by an initial excision of the loop peptide Gly143–Gly160 followed by the removal of a Val161–Ala162 dipeptide at the N terminus of the C-terminal 16-kDa TRAP subunit. Cathepsin L initially released a shorter Gln151–Gly160 peptide and completed processing at Ser145 or Gly143 at the C terminus of the N-terminal 23-kDa TRAP subunit and at Arg163 at the N terminus of the C-terminal 16-kDa TRAP subunit. Mutation of Ser145 to Ala partly mimicked the effect of proteolysis on catalytic activity, identifying Ser145 as well as Asp146 (Funhoff, E. G., Ljusberg, J., Wang, Y., Andersson, G., and Averill, B. A. (2001) Biochemistry 40, 11614–11622) as repressive amino acids of the loop region to maintain the TRAP enzyme in a catalytically latent state. The C-terminal sequence of TRAP isolated from rat bone was consistent with cathepsin K-mediated processing in vivo. Moreover, cathepsin K, but not cathepsin L, co-localized with TRAP in osteoclast-resorptive compartments, supporting a role for cathepsin K in the extracellular processing of monomeric TRAP in the resorption lacuna.


Received for publication, March 7, 2005 , and in revised form, May 27, 2005.

This paper is dedicated to the memory of Dr. Sandy C. Marks, Jr.

* This work was supported by grants from the Swedish Research Council (to G. A.) and Research Funds from Karolinska Institutet. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed: Dept. of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Karolinska University Hospital, S-141 86 Huddinge, Sweden. Fax: 46-8-585-87730; E-mail: Goran.Andersson{at}labmed.ki.se.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.